Purespring Therapeutics ^Companies

Purespring Therapeutics is an AAV gene therapy company that is leading a revolution in the treatment of kidney diseases globally. With over 8 million people in the UK and 840 million people worldwide suffering from chronic kidney disease, Purespring aims to provide transformative treatments for a range of kidney diseases. The organization is motivated by making a real difference to patients and their support systems who currently lack satisfactory treatment options. Purespring's mission is to bring disease-modifying therapies to patients with rare monogenic diseases and muc, offering new options beyond dialysis or kidney transplant that can adversely affect their quality of life.